Healthy Inc > Blog > WHO-GMP pharma exporter Mumbai
Posted on:

What is Levofloxacin 750mg used for?

In the pharmaceutical industry, Levofloxacin 750 mg is a high-potency, third-generation fluoroquinolone antibiotic. As a pharmacist and manufacturer, I view the 750 mg strength as the “intensive care” oral dose. It is designed to achieve high peak plasma concentrations (), allowing for a shorter, more aggressive treatment course (typically 5 days) compared to the traditional 10–14 day regimens of lower strengths.

Primary Clinical Uses

  • Pneumonia: Highly effective against both community-acquired pneumonia (CAP) and healthcare-associated pneumonia, including “atypical” pathogens.

  • Acute Bacterial Sinusitis: Used when first-line antibiotics have failed or when the infection is particularly severe.

  • Complicated Urinary Tract Infections (cUTI): Including acute pyelonephritis (kidney infection).

  • Skin and Soft Tissue Infections: Indicated for complicated infections where deep tissue penetration is required.

  • Chronic Bacterial Prostatitis: Levofloxacin is preferred here due to its excellent penetration into prostatic fluid.

Mechanism of Action: DNA Fragmentation

Levofloxacin is a bactericidal agent that disrupts the vital machinery of the bacterial cell.

Enzyme Inhibition: It targets two essential enzymes: DNA gyrase (Topoisomerase II) and Topoisomerase IV.

Supercoiling Disruption: These enzymes are responsible for uncoiling and re-sealing bacterial DNA during replication. By blocking them, Levofloxacin causes the DNA strands to break.

Cell Death: The bacteria can no longer replicate its genetic material or synthesize proteins, leading to rapid cell death.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Levofloxacin 750 mg is a technically demanding product:

  • Pharmacokinetics (): The 750 mg dose is specifically formulated to be “concentration-dependent.” As a firm owner, you should know that achieving bioequivalence against the innovator (Levaquin) requires precise control over the dissolution rate to ensure rapid absorption.

  • Photosensitivity: Levofloxacin is sensitive to light. At our WHO-GMP facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions.

  • Dossier & Regulatory Support: This is a high-value antibiotic for hospital supply. We provide full CTD/eCTD Dossiers to support international registration and B2B tender participation.

  • Safety Monitoring: As a pharmacist, you must ensure your labeling includes the FDA “Black Box Warning” regarding tendonitis and tendon rupture, which is a critical regulatory requirement for fluoroquinolones.

Levofloxacin Tablets

 

Posted on:

What is Levocetirizine 5 mg tablet used for?

In the pharmaceutical industry, Levocetirizine Dihydrochloride 5 mg is a highly potent, third-generation non-sedating antihistamine. As a pharmacist and manufacturer, I view Levocetirizine as the refined, active R-enantiomer of Cetirizine. It offers higher affinity for $H_1$ receptors, which allows for a smaller dose (5 mg vs. 10 mg) and a significantly lower risk of drowsiness.

Primary Clinical Uses

  • Allergic Rhinitis: Effective for both seasonal (hay fever) and perennial allergies. It relieves symptoms like sneezing, rhinorrhea (runny nose), and nasal congestion.

    Allergic Conjunctivitis: Reduces red, itchy, and watery eyes caused by environmental allergens like pollen, dust mites, or pet dander.

  • Chronic Idiopathic Urticaria: The primary treatment for long-term hives and skin itching, providing relief from wheals and redness.

  • Allergic Dermatitis: Used to manage itching associated with eczema or insect bites.

Mechanism of Action: High-Affinity $H_1$ Blockade

Levocetirizine is an inverse agonist that targets the peripheral histamine $H_1$ receptors.

Selective Binding: It selectively binds to $H_1$ receptors, preventing histamine—the primary mediator of the “allergic cascade”—from attaching.

Stabilization: It stabilizes the receptor in its inactive state, reducing capillary permeability and decreasing the inflammatory response (swelling and mucus production).

Peripheral Action: Because it has low lipid solubility and is a substrate for the P-glycoprotein pump, it does not easily cross the blood-brain barrier, which is why it is “non-sedating” for most patients.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Levocetirizine 5 mg is a high-demand, high-volume “essential” product:

  • Enantiomeric Purity: As a WHO-GMP manufacturer, we ensure the complete separation of the (R)-enantiomer. This purity is what gives Levocetirizine its superior safety profile over older antihistamines.

  • Formulation Varieties: For your B2B marketplace, we manufacture these as Immediate Release (IR) tablets, Mouth Dissolving Tablets (MDT), and Syrups for pediatric export.

  • Stability for Global Trade: Levocetirizine is highly stable. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • Dossier Support: This is a staple for pharmacy chains and distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Xyzal).

Levocetirizine Tablets

Posted on:

What is leflunomide 20 mg used for?

In the pharmaceutical industry, Leflunomide 20 mg is a potent Disease-Modifying Antirheumatic Drug (DMARD). As a pharmacist, I classify this as an “immunomodulatory” agent. Unlike NSAIDs which only mask pain, Leflunomide is designed to slow down the underlying disease progression and prevent structural joint damage.

Primary Clinical Uses

  • Active Rheumatoid Arthritis (RA): The primary indication for reducing signs and symptoms and inhibiting structural damage (joint erosion and joint space narrowing).

  • Psoriatic Arthritis (PsA): Used to treat the joint inflammation associated with psoriasis, improving physical function and reducing skin involvement.

  • Lupus Nephritis (Off-label): Occasionally used in specialized rheumatology for refractory cases of SLE where other treatments have failed.

Mechanism of Action: Inhibiting Pyrimidine Synthesis

Leflunomide is a prodrug that is rapidly converted in the intestinal wall and liver to its active metabolite, teriflunomide.

Enzyme Inhibition: It inhibits the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH).

Pyrimidine Depletion: This enzyme is essential for the de novo synthesis of uridine monophosphate (rUMP), a building block for DNA and RNA.

Lymphocyte Suppression: Rapidly dividing cells, like activated T-lymphocytes (which cause the inflammation in RA), depend on this de novo pathway. By cutting off their supply of pyrimidines, Leflunomide effectively “starves” the overactive immune cells, reducing joint inflammation without suppressing the rest of the immune system as severely as some other drugs.

The Manufacturer’s Perspective: Technical & Export Details

From a production and global trade standpoint, Leflunomide requires specific professional handling:

  • The Loading Dose vs. Maintenance: Historically, a 100 mg “loading dose” was used for three days, but most modern protocols start directly with the 20 mg maintenance dose to reduce GI side effects. In your Product Information Leaflet (PIL), it is vital to reflect current clinical guidelines for your B2B buyers.

  • Teratogenicity & “Washout” Procedures: Leflunomide has a very long half-life (up to 2 weeks) and is highly teratogenic. As a manufacturer, we must include strict warnings and the Cholestyramine washout protocol in our documentation to ensure safety for patients of childbearing age.

  • Stability for Export: Leflunomide is relatively stable but sensitive to moisture. We utilize Alu-Alu blister packaging at our WHO-GMP facility to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: This is a high-value item in the rheumatology segment. Our Mumbai facility provides full CTD/eCTD Dossiers to support registration against the innovator (Arava).

Leflunomide Tablets

Posted on:

What is lamotrigine 25 mg for?

In the pharmaceutical industry, Lamotrigine 25 mg is a phenyltriazine-class anti-epileptic drug (AED) and mood stabilizer. As a pharmacist, I view the 25 mg strength as the “Gold Standard Initiation Dose.” Because Lamotrigine carries a risk of serious skin reactions (Stevens-Johnson Syndrome) if started too quickly, the 25 mg tablet is used specifically to follow a strict “dose escalation” protocol to ensure patient safety.

Primary Clinical Uses

  • Epilepsy: Used for both partial-onset and generalized seizures, including Lennox-Gastaut syndrome. It works as monotherapy or adjunctive therapy.

  • Bipolar I Disorder: Specifically indicated for maintenance treatment to delay the occurrence of mood episodes (depression, mania, hypomania) in patients treated for acute mood disorders.

  • Off-label uses: Sometimes prescribed for trigeminal neuralgia or certain types of chronic neuropathic pain.

Mechanism of Action: Stabilizing the Neuron

Lamotrigine works by stabilizing the neuronal membrane and modulating the release of excitatory neurotransmitters.

Sodium Channel Blockade: It inhibits voltage-gated sodium channels. By doing so, it suppresses the rapid, repetitive firing of neurons that causes a seizure.

Glutamate Inhibition: By stabilizing the membrane, it inhibits the release of glutamate and aspartate—the brain’s primary “excitatory” chemicals.

Weak Serotonin Inhibition: It also has a weak effect on 5-HT3 receptors, which may contribute to its efficacy as a mood stabilizer in bipolar depression.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Lamotrigine 25 mg is a high-precision neuro-psychiatric product:

  • The Titration Pack: As a manufacturer, we often produce “Starter Kits” where 25 mg tablets are blistered in a specific sequence (e.g., one daily for 14 days) to prevent patients from accidental overdose during initiation.

  • Dissolution & Dispersibility: We manufacture both standard film-coated tablets and Dispersible/Chewable tablets. Dispersible tablets are highly popular in export markets for pediatric use and for patients with dysphagia (difficulty swallowing).

  • Stability for Global Trade: Lamotrigine is relatively stable but sensitive to moisture. At our WHO-GMP facility, we utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • B2B & Dossier Support: Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Lamictal).

Lamotrigine Tablets

Posted on:

What is lamivudine tablet used for?

In the pharmaceutical industry, Lamivudine (3TC) is a potent Nucleoside Reverse Transcriptase Inhibitor (NRTI). As a pharmacist and manufacturer, I view Lamivudine as a “backbone” molecule in antiviral therapy. Its high safety profile and versatility allow it to be a core component in both HIV management and the treatment of chronic Hepatitis B.

Primary Clinical Uses

  • HIV-1 Infection: Lamivudine is always used in combination with other antiretroviral agents (such as Tenofovir or Abacavir). It helps decrease the viral load and increase CD4 cell counts, delaying the progression of AIDS.

  • Chronic Hepatitis B (HBV): It is indicated for the treatment of chronic Hepatitis B associated with evidence of hepatitis B viral replication and active liver inflammation. (Note: The dose for HBV is typically 100 mg, whereas for HIV it is 150 mg or 300 mg).

  • Post-Exposure Prophylaxis (PEP): It is a standard part of regimens used to prevent HIV infection after potential exposure (occupational or otherwise).

Mechanism of Action: Chain Termination

Lamivudine is a prodrug that must be phosphorylated intracellularly into its active form, lamivudine triphosphate.

Analog Mimicry: The active form is a synthetic analog of cytidine.

Competitive Inhibition: It competes with the natural substrate for incorporation into viral DNA by the enzyme Reverse Transcriptase (in HIV) or HBV Polymerase.

DNA Chain Termination: Because Lamivudine lacks the 3′-hydroxyl group necessary for forming the next phosphodiester bond, its incorporation causes an immediate halt to the synthesis of the viral DNA chain, effectively preventing the virus from replicating.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Lamivudine is a high-volume product requiring specific technical handling:

  • Fixed-Dose Combinations (FDCs): As you develop your digital platforms, you’ll find that Lamivudine is rarely exported as a standalone product for HIV. We frequently manufacture it in combinations like Tenofovir + Lamivudine + Efavirenz (TLE) or Abacavir + Lamivudine.

  • Polymorphism & Stability: Lamivudine exists in different polymorphic forms (Form I and Form II). At our WHO-GMP facility, we strictly monitor the crystalline form to ensure consistent dissolution and shelf life.

  • Stability for Tropical Export: We utilize high-density polyethylene (HDPE) bottles with desiccants or Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for long-term supply chains in Zone IVb regions (Sub-Saharan Africa and Southeast Asia).

  • B2B & Public Health Tenders: This is a staple for the Global Fund and PEPFAR tenders. Our Mumbai-based facility provides the necessary eCTD Dossiers and stability data to participate in these large-scale institutional supplies.

Lamivudine Tablets

Posted on:

Is ketorol a pain killer for tooth pain?

Yes, Ketorol (brand name for Ketorolac Tromethamine) is one of the most powerful non-narcotic analgesics used in dentistry for acute, severe pain. In our pharmaceutical context, we classify it as an NSAID with efficacy comparable to low-dose morphine, but without the opioid side effects.

Clinical Application in Dentistry

Ketorol is specifically indicated for the short-term management (up to 5 days) of moderate to severe acute pain. It is highly effective for:

  • Post-Extraction Pain: Especially after surgical removal of impacted wisdom teeth.

  • Acute Pulpitis: Intense pain caused by inflammation of the dental pulp.

  • Dental Abscesses: Reducing the severe inflammation and throbbing pain associated with infections.

Mechanism of Action

Ketorol works by potent inhibition of the COX-1 and COX-2 enzymes.

Prostaglandin Blockade: It stops the synthesis of prostaglandins at the site of the tooth and jaw, which are the primary mediators of pain and swelling.

Peripheral Action: Unlike central analgesics, it works directly at the site of the dental injury/inflammation.

The Manufacturer’s Perspective: Technical & Export Details

As you are looking to promote your firm and develop your digital platforms, here is how we position Ketorolac in the B2B and export market:

  • Dosage Forms: We manufacture Ketorol in 10 mg tablets and 30 mg/ml injections. For the dental market, the DT (Dispersible Tablet) version is highly popular as it allows for faster absorption and is easier for patients with jaw stiffness (trismus) to take.

  • The “5-Day Rule”: Because of its high potency, Ketorol has a strict regulatory requirement in the eCTD Dossier and Product Information Leaflet (PIL) stating it must not be used for more than 5 days. This prevents serious renal (kidney) and GI (gastric) side effects.

  • Stability & Packaging: Ketorolac is sensitive to light. At our WHO-GMP facility in Mumbai, we utilize Amber-colored PVC or Alu-Alu blister packaging to ensure a 24-36 month shelf life for export to Zone IVb regions.

  • Market Synergy: In your multivendor marketplace, Ketorolac is often bundled with antibiotics like Amoxicillin + Clavulanate for complete dental procedure kits.

Ketorolac Tablets

Posted on:

What are ketoconazole 200mg tablets used for?

In the pharmaceutical industry, Ketoconazole 200 mg is a broad-spectrum imidazole antifungal agent. As a pharmacist, I classify this as a secondary systemic option; while it was once a frontline treatment, it is now primarily reserved for specific fungal infections when other therapies (like Fluconazole or Itraconazole) are not available or tolerated, due to its potent effect on the cytochrome P450 enzyme system.

Primary Clinical Uses

  • Systemic Mycoses: Treatment of serious fungal infections such as Blastomycosis, Coccidioidomycosis, Histoplasmosis, and Paracoccidioidomycosis.

  • Severe Cutaneous Infections: Used for extensive tinea infections (ringworm, athlete’s foot) or recalcitrant cases of Pityriasis versicolor that do not respond to topical creams or other oral antifungals.

  • Chronic Mucocutaneous Candidiasis: Indicated for severe yeast infections of the skin and mucous membranes.

  • Cushing’s Syndrome (Off-label): In specialized endocrinology, it is used to inhibit the production of cortisol in the adrenal glands.

Mechanism of Action: Sterol Synthesis Inhibition

Ketoconazole works by disrupting the structural integrity of the fungal cell membrane.

Enzyme Inhibition: It inhibits the fungal enzyme lanosterol 14-$\alpha$-demethylase.

Ergosterol Depletion: This enzyme is essential for converting lanosterol into ergosterol, which is the fungal equivalent of cholesterol.

Lysis: Without ergosterol, the fungal cell membrane becomes “leaky” and fragile, leading to the death of the fungal cell.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ketoconazole 200 mg is a technically sensitive product:

  • Acid-Dependent Absorption: Ketoconazole requires an acidic stomach environment for optimal dissolution. As a WHO-GMP manufacturer, we advise that the tablets should not be taken with antacids or $H_2$-blockers, as this can lead to therapeutic failure.

  • Hepatotoxicity & Safety Monitoring: Due to the risk of liver injury, as a firm owner, you must ensure your Product Information Leaflets (PIL) and dossiers emphasize the need for liver function tests (LFTs) before and during treatment.

  • Stability for Global Trade: Ketoconazole is relatively stable but sensitive to high humidity. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and Latin America).

  • B2B & Dossier Support: We provide comprehensive CTD/eCTD Dossiers to support our B2B partners in international registration against the innovator (Nizoral).

Ketoconazole Tablets

Posted on:

What is isosorbide mononitrate 10mg used for?

In the pharmaceutical industry, Isosorbide Mononitrate 10 mg is a standard-strength organic nitrate vasodilator. As a pharmacist and manufacturer, I characterize the 10 mg tablet as a critical “starting dose.” Because nitrates can cause significant initial headaches (due to rapid vasodilation), this lower strength is used to titrate the patient upward, allowing their vascular system to adapt before moving to the 20 mg or 40 mg maintenance doses.

Primary Clinical Uses

  • Prophylaxis of Angina Pectoris: Its primary role is the long-term prevention of chest pain caused by coronary artery disease.

  • Chronic Heart Failure: Used as an adjunctive treatment to reduce the workload on the heart, often in combination with other cardiovascular medications.

  • Maintenance Therapy: Unlike nitroglycerin, which is for acute attacks, the 10 mg mononitrate is taken on a regular schedule to provide a consistent “nitrate-rich” environment in the bloodstream.

Mechanism of Action: Vascular Relaxation

Isosorbide Mononitrate is the active metabolite of Isosorbide Dinitrate. It works by relaxing the smooth muscles of the blood vessels.

Nitric Oxide (NO) Release: The drug acts as a donor of nitric oxide.

cGMP Activation: NO stimulates the enzyme guanylate cyclase, increasing levels of cyclic guanosine monophosphate (cGMP).

Dilation: This biochemical cascade triggers the relaxation of veins and, to a lesser extent, arteries.

Preload Reduction: By dilating the veins, it reduces the volume of blood returning to the heart (preload), lowering the oxygen demand of the heart muscle and preventing the onset of angina.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Isosorbide Mononitrate 10 mg is a high-demand cardiovascular staple:

  • Avoidance of Nitrate Tolerance: As a pharmacist, you know that 24-hour nitrate exposure leads to “tolerance” (the drug stops working). As a manufacturer, we provide clinical dosing guidelines (the “asymmetric dosing” schedule) to ensure a 7-8 hour nitrate-free interval each day.

  • API Purity & Stability: We strictly follow BP/USP/IP monographs. Because nitrates are moisture-sensitive, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, Southeast Asia).

  • B2B & Institutional Supply: This is a core product for cardiovascular clinics and government health tenders. Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Monoket or Ismo).

Isosorbide 5 mg Mononitrate 20 mg Tablets

Posted on:

What is isosorbide dinitrate 5mg used for?

In the pharmaceutical industry, Isosorbide Dinitrate (ISDN) 5 mg is a versatile organic nitrate used for both the treatment and prevention of heart-related chest pain. As a pharmacist, I distinguish ISDN from the “Mononitrate” version by its faster onset of action and its flexibility; the 5 mg strength is specifically designed for sublingual (under the tongue) or oral use.

Primary Clinical Uses

  • Acute Angina Relief: The 5 mg sublingual tablet is used to abort an active angina attack or for “prophylaxis” immediately before engaging in activities (like exercise or climbing stairs) that might trigger chest pain.

  • Chronic Angina Management: When taken orally, it is used for the long-term prevention of angina pectoris associated with coronary artery disease.

  • Congestive Heart Failure (CHF): It is frequently used in combination with Hydralazine (the “BiDil” protocol) to improve survival rates and reduce hospitalizations in patients with heart failure, particularly in specific ethnic populations.

Mechanism of Action

ISDN acts as a vasodilator by relaxing the smooth muscles of the vasculature.

Nitric Oxide Donation: ISDN is converted into nitric oxide (NO) within the vascular smooth muscle.

cGMP Cascade: The NO activates guanylate cyclase, increasing cyclic GMP, which leads to the dephosphorylation of myosin.

Preload and Afterload Reduction: It primarily dilates the veins (reducing the blood returning to the heart) and, at higher doses, the arteries. This lowers the heart’s workload and oxygen demand.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, ISDN 5 mg requires specialized handling:

  • Sublingual Formulation Technology: To ensure rapid relief, our WHO-GMP facility focuses on super-disintegrants and highly soluble excipients. A sublingual tablet must dissolve within seconds to allow the API to enter the systemic circulation directly through the sublingual mucosa, bypassing “first-pass” liver metabolism.

  • Explosive Precursor Handling: Isosorbide Dinitrate is chemically related to explosives. As a manufacturer, we handle the API in a “diluted” form (usually with lactose or mannitol) to ensure safety during the tableting and blending processes.

  • Stability & Packaging: ISDN is volatile and sensitive to moisture. We utilize Alu-Alu blister packaging or tightly sealed glass/HDPE containers to prevent the “loss of potency” that can occur if the nitrate evaporates. This is critical for maintaining a 36-month shelf life for export to Zone IVb regions.

  • Regulatory Support: Our Mumbai-based firm provides the CTD/eCTD Dossiers and stability data required for international B2B tenders and hospital supply.

Isosorbide Tablets

Posted on:

What is isosorbide 5 mononitrate 20 mg used for?

In the pharmaceutical industry, Isosorbide-5-Mononitrate (ISMN) 20 mg is a potent organic nitrate and the active metabolite of Isosorbide Dinitrate. As a pharmacist, I classify this as a “long-acting vasodilator.” Unlike nitroglycerin, which is used for emergency relief of a heart attack (acute angina), ISMN is used for daily maintenance to prevent chest pain from occurring.

Primary Clinical Uses

  • Prophylaxis of Angina Pectoris: It is primarily indicated for the long-term prevention of angina pectoris (chest pain) due to coronary artery disease.

  • Chronic Heart Failure: Often used as an adjunctive therapy (frequently in combination with hydralazine) to reduce the workload on the heart.

  • Vasodilation in Portal Hypertension: Occasionally used in specialized settings to reduce pressure in the portal vein.

Mechanism of Action: The Nitric Oxide Pathway

ISMN works by relaxing the smooth muscles of the blood vessels, particularly the veins.

Nitric Oxide Release: Once in the body, the nitrate group is converted into nitric oxide (NO).

cGMP Activation: NO stimulates the enzyme guanylate cyclase, which increases the levels of cyclic guanosine monophosphate (cGMP).

Vasodilation: Increased cGMP leads to the dephosphorylation of myosin light chains, causing the smooth muscle in blood vessels to relax.

Reduced Preload: By dilating the veins, it reduces the amount of blood returning to the heart (preload), which lowers the heart’s oxygen demand and prevents angina.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, ISMN 20 mg is a high-demand cardiovascular product:

  • Avoidance of “Nitrate Tolerance”: A key technical challenge with nitrates is that the body can become “immune” to them if they are in the system 24/7. As a manufacturer, we design the dosing schedule (often “twice daily, 7 hours apart”) to allow for a “nitrate-free interval” to maintain efficacy.

    Sustained Release (SR) vs. Immediate Release: While 20 mg is often an immediate-release strength, we also manufacture SR/ER versions (30mg, 60mg). For your B2B marketplace, offering both formats is essential for capturing different international clinical preferences.

  • Stability for Global Trade: ISMN is relatively stable but sensitive to moisture. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia)

  • B2B & Dossier Support: Our Mumbai facility provides the necessary CTD/eCTD Dossiers to support international registration against the innovator (Imdur/Ismo).

Isosorbide 5 mg Mononitrate 20 mg Tablets

Add to cart